The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Artificial intelligence (AI) as a decision support tool for practicing oncologists.
 
Mohammad Jahanzeb
Stock and Other Ownership Interests - PrecisCa
Honoraria - Becton Dickinson
Consulting or Advisory Role - Abbvie; AstraZeneca; Becton Dickinson; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Merck; Novartis; Novocure; Pfizer; Puma Biotechnology; Stemline Therapeutics; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Celgene; Gilead Sciences; Merck; Regeneron; Stemline Therapeutics; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Becton Dickinson; Gilead Sciences; Merck; Novocure; Regeneron; Stemline Therapeutics; takeda
 
Kayla Haines
Employment - Florida Cancer Specialists and Research Institute; OncAdvisor
Consulting or Advisory Role - Janssen Oncology; Precisca; Takeda
 
David Camidge
Honoraria - Abbvie; Apollomics; AstraZeneca; Daiichi Sankyo; Janssen; Kestrel Labs; Lilly; Nuvalent, Inc.; Roche; takeda
Research Funding - Inivata (Inst)
 
Walter Curran
Leadership - Lumonus
Stock and Other Ownership Interests - Arterra; Lumonus; Nanthealth
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb
 
William Gradishar
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Gilead Sciences; merck; Novartis; Pfizer
 
Sara Hurvitz
Stock and Other Ownership Interests - ROM Tech (I)
Research Funding - Ambryx (Inst); Amgen (Inst); Arvinas (Inst); AstraZeneca/Daiichi Sankyo (Inst); Bayer (Inst); Biomarin (Inst); Cascadian Therapeutics (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Dantari (Inst); Dignitana (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Greenwich LifeSciences (Inst); Immunomedics (Inst); Lilly (Inst); Loxo/Lilly (Inst); Macrogenics (Inst); Merrimack (Inst); Novartis (Inst); Orinove (Inst); Orum (Inst); Pfizer (Inst); Phoenix Molecular Designs (Inst); Pieris Pharmaceuticals (Inst); Puma Biotechnology (Inst); Radius Health (Inst); Samumed (Inst); sanofi (Inst); Seagen (Inst); Stemline/Menarini (Inst); Zymeworks (Inst)
Other Relationship - BeiGene (Inst); BMS (Inst); Boehringer Ingelheim; Briacell (Inst); BridgeBio Pharma (Inst); Celcuity; Embiosys; Gilead Sciences (Inst); InClin/Atossa; Jazz Pharmaceuticals (Inst); Luminate (Inst); Medsir; Mersana (Inst); Novartis; Pfizer; Roche; Roche (Inst)
 
Tari King
Honoraria - Exact Sciences; Presica
Consulting or Advisory Role - GE Healthcare; Veracyte
Research Funding - PreludeDx (Inst)
Travel, Accommodations, Expenses - Grupo Oncoclinicas; Veracyte
 
Benjamin Levy
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Daiichi Sankyo/Astra Zeneca; Genentech/Roche; Guardant Health; Janssen Oncology; Merck; Mirati Therapeutics; Novartis; Novocure; Pfizer; Sanofi
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Loxo (Inst); Merck (Inst); Turning Point Therapeutics (Inst)
 
Stephen Liu
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Genentech; Gilead Sciences; GlaxoSmithKline; Guardant Health; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Merus; Mirati Therapeutics; MSD Oncology; Natera; Novartis; OSE Immunotherapeutics; Pfizer; RAPT Therapeutics; Regeneron; Revolution Medicines; Takeda; Yuhan
Research Funding - Abbvie (Inst); Alkermes (Inst); AstraZeneca (Inst); Bristol Myers Squibb Foundation (Inst); Cogent Biosciences (Inst); Duality Biologics (Inst); Elevation Oncology (Inst); Ellipses Pharma (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Merck (Inst); Merus (Inst); Nuvalent, Inc. (Inst); OSE Immunotherapeutics (Inst); Puma Biotechnology (Inst); RAPT Therapeutics (Inst); Systimmune (Inst)
(OPTIONAL) Uncompensated Relationships - Roche/Genentech
 
Reshma Mahtani
Consulting or Advisory Role - Agendia; Amgen; Daiichi Sankyo/Astra Zeneca; Eisai; Genentech/Roche; Gilead Sciences; Hologic/Biotheranostics; Lilly; Merck; Novartis; Pfizer; Puma Biotechnology; Sanofi; Sermonix Pharmaceuticals; Stemline Therapeutics
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Agendia; Amgen; AstraZeneca; bioTheranostics; Daiichi Sankyo/Lilly; Eisai; Genentech/Roche; Lilly; Merck; Novartis; Pfizer; Puma Biotechnology; Sanofi; Seagen
 
Monica Morrow
Honoraria - Roche TCRC
 
Anne O'Dea
Honoraria - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Pfizer; Puma Biotechnology; Stemline Therapeutics
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis; Pfizer; Puma Biotechnology; Seagen; Stemline Therapeutics
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Pfizer; Puma Biotechnology; Stemline Therapeutics
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Pfizer; Puma Biotechnology; Stemline Therapeutics
 
Joyce O'Shaughnessy
Honoraria - AADi; Agendia; Amgen; Aptitude Health; AstraZeneca; BioNTech; Bristol-Myers Squibb; Daiichi Sankyo; DAVA Oncology; DualityBio; Eisai; Ellipses Pharma; Exact Sciences; G1 Therapeutics; Genentech; Gilead Sciences; Guardant Health; HiberCell; Jazz Pharmaceuticals; Johnson & Johnson; Lilly; Menarini Group; Merck; Mersana; Natera; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Roche; Sanofi; Seagen; Stemline Therapeutics; Summit Therapeutics; Tempus; Tersera
Consulting or Advisory Role - AADi; Agendia; Amgen; Aptitude Health; AstraZeneca; BioNTech; Bristol-Myers Squibb; Daiichi Sankyo; DAVA Oncology; DualityBio; Eisai; Ellipses Pharma; Exact Sciences; G1 Therapeutics; Genentech; Gilead Sciences; Guardant Health; HiberCell; Jazz Pharmaceuticals; Johnson & Johnson; Lilly; Menarini Group; Merck; Mersana; Natera; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Roche; Sanofi; Seagen; Stemline Therapeutics; Summit Therapeutics; Tempus; Tersera
Travel, Accommodations, Expenses - Aptitude Health; Daiichi Sankyo; DAVA Oncology; Lilly; Merck; Novartis; Roche
 
Varun Puri
Stock and Other Ownership Interests - Intuitive Surgical (I)
Honoraria - Precisca
 
Suresh Ramalingam
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie
Other Relationship - American Cancer Society
 
Chirag Shah
Employment - Allegheny Health Network
Consulting or Advisory Role - ImpediMed; PreludeDx; Videra Surgical
Research Funding - PreludeDx; PreludeDx; Varian Medical Systems
 
Mark Socinski
Honoraria - Arcus Biosciences; AstraZeneca; Bayer; Bristol-Myers Squibb; Coherus Biosciences; G1 Therapeutics; Genentech; Gilead Sciences; GlaxoSmithKline; GlaxoSmithKline; Gritstone Bio; Guardant Health; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Merck; Mirati Therapeutics; Novartis; Regeneron; Roche/Genentech; Spectrum Pharmaceuticals; Takeda
Consulting or Advisory Role - BMSi; Genentech; Janssen; Lilly; OncoC4; Spectrum Pharmaceuticals
Speakers' Bureau - Amgen; AstraZeneca; Blueprint Medicines; Bristol-Myers Squibb; G1 Therapeutics; Genentech; Guardant Health; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Merck; Sanofi/Regeneron; Takeda
Research Funding - AstraZeneca/MedImmune (Inst); BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Enliven Therapeutics (Inst); Genentech (Inst); Mirati Therapeutics (Inst); Spectrum Pharmaceuticals (Inst)
 
Tom Stinchcombe
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Coherus Biosciences; Gilead Sciences; Janssen Oncology; Pfizer; Takeda
Research Funding - Boehringer Ingelheim (Inst); Mirati Therapeutics (Inst); Nuvalent, Inc. (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Pfizer
Other Relationship - Genentech; GlaxoSmithKline; Merck; Seagen